Organization name
Medical Oncology
Parent OrgUnit
City
Heidelberg, Victoria
Country
Australia


Results 41-60 of 194 (Search time: 0.017 seconds).

Publication YearTitleAuthor(s)
4114-Jul-2022Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.Shah, Manish A; Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Tebbutt, Niall C ; Metges, Jean-Phillippe; Muro, Kei; Lee, Keun-Wook; Shen, Lin; Tjulandin, Sergei; Hays, John L; Starling, Naureen; Xu, Rui-Hua; Sturtz, Keren; Fontaine, Marilyn; Oh, Cindy; Brooks, Emily M; Xu, Bo; Li, Wei; Li, Chiang J; Borodyansky, Laura; Van Cutsem, Eric
422-Jun-2022Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry).Gately, Lucy; Drummond, Katharine; Rosenthal, Mark; Harrup, Rosemary; Dowling, Anthony; Gogos, Andrew; Lwin, Zarnie; Collins, Ian; Campbell, David; Ahern, Elizabeth; Phillips, Claire; Gan, Hui K ; Bennett, Iwan; Sieber, Oliver M; Gibbs, Peter
431-Jun-2022Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial.Majem, Margarita; Goldman, Jonathan W; John, Thomas ; Grohe, Christian; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu Vinh; Lu, Shun; Li, Shanqing; Lee, Kye Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Atagi, Shinji; Zeng, Lingmin; Kulkarni, Dakshayini; Medic, Nenad; Tsuboi, Masahiro; Herbst, Roy S; Wu, Yi-Long
4413-May-2022Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin.Berthelet, Jean; Foroutan, Momeneh; Bhuva, Dharmesh D; Whitfield, Holly J; El-Saafin, Farrah; Cursons, Joseph; Serrano, Antonin; Merdas, Michal; Lim, Elgene; Charafe-Jauffret, Emmanuelle; Ginestier, Christophe; Ernst, Matthias ; Hollande, Frédéric; Anderson, Robin L ; Pal, Bhupinder; Yeo, Belinda ; Davis, Melissa J; Merino, Delphine
452-May-2022Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer.Weickhardt, Andrew J ; Lau, David K ; Hodgson-Garms, Margeaux; Lavis, Austen; Jenkins, Laura J; Vukelic, Natalia; Ioannidis, Paul; Luk, Ian Y; Mariadason, John M 
46May-2022Primary CNS lymphoma in the real world-Opportunities for improved outcomes in different health settingsParakh, Sagun ; Gan, Hui K 
478-Apr-2022'Know thyself'- host factors influencing cancer response to immune checkpoint inhibitors.Gunjur, Ashray ; Manrique-Rincón, Andrea J; Klein, Oliver ; Behren, Andreas; Lawley, Trevor D; Welsh, Sarah J; Adams, David J
4811-Mar-2022Radiolabeled Antibodies for Cancer Imaging and Therapy.Parakh, Sagun ; Lee, Sze Ting ; Gan, Hui K ; Scott, Andrew M 
4924-Jan-2022VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.Chionh, Fiona; Gebski, Val; Al-Obaidi, Sheren J; Mooi, Jennifer K ; Bruhn, Maressa A; Lee, Chee K; Chüeh, Anderly C; Williams, David S ; Weickhardt, Andrew J ; Wilson, Kate; Scott, Andrew M ; Simes, John; Hardingham, Jennifer E; Price, Timothy J; Mariadason, John M ; Tebbutt, Niall C 
5017-Jan-2022Practical guidance for telemedicine use in neuro-oncology.Strowd, Roy E; Dunbar, Erin M; Gan, Hui K ; Kurz, Sylvia; Jordan, Justin T; Mandel, Jacob J; Mohile, Nimish A; Nevel, Kathryn S; Taylor, Jennie W; Ullrich, Nicole J; Welch, Mary R; Wasilewski, Andrea; Mrugala, Maciej M
512022Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.Dimitriou, F; Namikawa, K; Reijers, I L M; Buchbinder, E I; Soon, J A; Zaremba, A; Teterycz, P; Mooradian, M J; Armstrong, E; Nakamura, Y; Vitale, M G; Tran, L E; Bai, X; Allayous, C; Provent-Roy, S; Indini, A; Bhave, P; Farid, M; Kähler, K C; Mehmi, I; Atkinson, V; Klein, Oliver ; Stonesifer, C J; Zaman, F; Haydon, A; Carvajal, R D; Hamid, O; Dummer, R; Hauschild, A; Carlino, M S; Mandala, M; Robert, C; Lebbe, C; Guo, J; Johnson, D B; Ascierto, P A; Shoushtari, A N; Sullivan, R J; Cybulska-Stopa, B; Rutkowski, P; Zimmer, L; Sandhu, S ; Blank, C U; Lo, S N; Menzies, A M; Long, G V
5230-Dec-2021LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study.Kong, Benjamin Y; Sim, Hao-Wen; Nowak, Anna K; Yip, Sonia; Barnes, Elizabeth H; Day, Bryan W; Buckland, Michael E; Verhaak, Roel; Johns, Terrance; Robinson, Cleo; Thomas, Marc A; Giardina, Tindaro; Lwin, Zarnie; Scott, Andrew M ; Parkinson, Jonathon; Jeffree, Rosalind; Lourenco, Richard de Abreu; Hovey, Elizabeth J; Cher, Lawrence M ; Kichendasse, Ganessan; Khasraw, Mustafa; Hall, Merryn; Tu, Emily; Amanuel, Benhur; Koh, Eng-Siew; Gan, Hui K 
533-Dec-2021Antibody Drug Conjugates in Glioblastoma - Is There a Future for Them?Parakh, Sagun ; Nicolazzo, Joseph; Scott, Andrew M ; Gan, Hui K 
542-Dec-2021Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].Reck, M; Ciuleanu, T-E; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Bennouna, J; Felip, E; Juan-Vidal, O; Alexandru, A; Sakai, H; Lingua, A; Reyes, F; Souquet, P-J; De Marchi, P; Martin, C; Pérol, M; Scherpereel, A; Lu, S; Paz-Ares, L; Carbone, D P; Memaj, A; Marimuthu, S; Zhang, X; Tran, P; John, Thomas 
551-Dec-2021A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer.Wu, Yi-Long; Tsuboi, Masahiro; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee, Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S
1615-Nov-2021Recent Research on Combination of Radiotherapy with Targeted Therapy or Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Review for Radiation Oncologists.Xing, Daniel T ; Khor, Richard ; Gan, Hui K ; Wada, Morikatsu ; Ermongkonchai, Tai; Ng, Sweet Ping 
175-Nov-2021Update on optimal management for pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.Nguyen, Mike ; Segelov, Eva; Goldstein, David; Pavlakis, Nick; Shapiro, Jeremy; Price, Timothy J; Nagrial, Adnan; Chantrill, Lorraine; Leong, Trevor; Chen, John; Burge, Matt; Karapetis, Christos S; Chau, Ian; Lordick, Florian; Renouf, Daniel; Tebbutt, Niall C ; Roy, Amitesh C
181-Nov-2021A Randomized Phase 2 Trial of Nivolumab and Stereotactic Ablative Body Radiotherapy (SABR) in Advanced Non-Small Cell Lung Cancer, Progressing After First- or Second-Line Chemotherapy (NIVORAD).Mitchell, Paul L R ; O'Byrne, K J; Brown, C; Jurkovic, H; Karapetis, C S; Kok, P S; Lao, L; Le, H V; Pavlakis, N; Ab Rahman, A S; Subramaniam, S; Walker, M; Yip, S; Stockler, M R; Siva, S
19Nov-2021Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial.Klein, Oliver ; Kee, Damien ; Gao, Bo; Markman, Ben; da Gama Duarte, Jessica; Quigley, Luke; Jackett, Louise A ; Linklater, Richelle; Strickland, Andrew; Scott, Clare; Mileshkin, Linda; Palmer, Jodie ; Carlino, Matteo; Behren, Andreas; Cebon, Jonathan S 
20Nov-2021Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease.McLean, Luke S; Faisal, Wasek; Parakh, Sagun ; Kao, Steven C; Lewis, Craig R; Chin, Melvin T; Voskoboynik, Mark; Itchins, Malinda J; Jennens, Ross R; Broad, Adam R; Morris, Tessa A; Solomon, Benjamin J